053950 — Kyung Nam Pharm Co Income Statement
0.000.00%
Last trade - 00:00- KR₩58bn
- KR₩43bn
- KR₩61bn
- 13
- 54
- 20
- 14
Annual income statement for Kyung Nam Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 70,947 | 64,623 | 59,000 | 59,303 | 60,792 |
| Cost of Revenue | |||||
| Gross Profit | 28,473 | 21,075 | 16,394 | 19,298 | 17,225 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 68,767 | 71,573 | 64,901 | 63,748 | 61,416 |
| Operating Profit | 2,180 | -6,949 | -5,900 | -4,445 | -624 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7,492 | -3,299 | -7,395 | -8,592 | -3,220 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5,488 | -3,209 | -7,828 | -9,570 | -4,082 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -5,488 | -3,413 | -7,828 | -20,997 | 10,076 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5,488 | -3,413 | -7,828 | -20,997 | 10,076 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -218 | -135 | -163 | -193 | -88.3 |
| Dividends per Share |